Schoenfeld JD, Azad NS, Gross J, Chen L, et al. Next-Generation Sequencing-Based MSI Scoring Predicts Benefit in Mismatch Repair-Deficient Tumors Treated with Nivolumab: Follow-up on NCI-MATCH Arm Z1D. Clin Cancer Res 2025;31:667-677.
PMID: 39670863